Allogenic Platelet-Rich Plasma for Treating Cartilage Injury: A Systematic Review of the Evidence on the Basic Sciences for Potential Future Applications
It is apparent that whilst many reports are available regarding platelet-rich-plasma (PRP), the larger majority of these have been mainly focussed on autologous sources, and for good reason. Issues relating to allogenic source have been consciously avoided owing to concerns of cross infectivity and...
Uloženo v:
| Vydáno v: | Cells, tissues, organs Ročník 213; číslo 4; s. 338 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Switzerland
01.08.2024
|
| Témata: | |
| ISSN: | 1422-6421, 1422-6421 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | It is apparent that whilst many reports are available regarding platelet-rich-plasma (PRP), the larger majority of these have been mainly focussed on autologous sources, and for good reason. Issues relating to allogenic source have been consciously avoided owing to concerns of cross infectivity and immune rejection. However, this topic today is now revisited and is of interest since progress over the year has demonstrated its safety, efficacy, and its abundance of supply. The present systematic review was thus conducted to elucidate advances made in this area, with the aim to provide a wider and deeper understanding of studies relevant to the application of allogenic PRP in cartilage repair. Literature search was conducted systematically using Medline, ProQuest, Web of Science, Cochrane Central Register of Controlled Trials, and snowballing searching strategy to identify relevant studies using topic-specific keywords in various combinations including "allogenic, platelet, rich, plasma" OR "allogeneic, platelet, rich, plasma" OR "allogenic platelet-rich plasma" OR "allogeneic platelet-rich plasma" OR "allogenic platelet rich plasma" OR "allogeneic platelet rich plasma" AND cartilage OR chondrocytes OR synoviocytes OR stem cells. Studies that used allogenic PRP in an attempt to facilitate cartilage repair were included. The risk of bias was assessed by the SYRCLE's checklist. Of 206 studies identified, 12 were found eligible. Only those studies that are clearly related and specific to allogenic PRP were included. Of these, nine investigated the efficacy of allogenic PRP in animal models, while three articles employed an in vitro model. Allogenic PRP promotes cell proliferation, cartilage matrix production, and anti-inflammatory effects in vitro. The in vivo studies reported histological evidence of significant acceleration of cartilage repair in treated animals. Despite several conflicting findings, all studies agreed that allogenic PRP is safe and potentially efficacious for cartilage repair, with the advantages of allogenic sources apparent. |
|---|---|
| AbstractList | It is apparent that whilst many reports are available regarding platelet-rich-plasma (PRP), the larger majority of these have been mainly focussed on autologous sources, and for good reason. Issues relating to allogenic source have been consciously avoided owing to concerns of cross infectivity and immune rejection. However, this topic today is now revisited and is of interest since progress over the year has demonstrated its safety, efficacy, and its abundance of supply. The present systematic review was thus conducted to elucidate advances made in this area, with the aim to provide a wider and deeper understanding of studies relevant to the application of allogenic PRP in cartilage repair. Literature search was conducted systematically using Medline, ProQuest, Web of Science, Cochrane Central Register of Controlled Trials, and snowballing searching strategy to identify relevant studies using topic-specific keywords in various combinations including "allogenic, platelet, rich, plasma" OR "allogeneic, platelet, rich, plasma" OR "allogenic platelet-rich plasma" OR "allogeneic platelet-rich plasma" OR "allogenic platelet rich plasma" OR "allogeneic platelet rich plasma" AND cartilage OR chondrocytes OR synoviocytes OR stem cells. Studies that used allogenic PRP in an attempt to facilitate cartilage repair were included. The risk of bias was assessed by the SYRCLE's checklist. Of 206 studies identified, 12 were found eligible. Only those studies that are clearly related and specific to allogenic PRP were included. Of these, nine investigated the efficacy of allogenic PRP in animal models, while three articles employed an in vitro model. Allogenic PRP promotes cell proliferation, cartilage matrix production, and anti-inflammatory effects in vitro. The in vivo studies reported histological evidence of significant acceleration of cartilage repair in treated animals. Despite several conflicting findings, all studies agreed that allogenic PRP is safe and potentially efficacious for cartilage repair, with the advantages of allogenic sources apparent.It is apparent that whilst many reports are available regarding platelet-rich-plasma (PRP), the larger majority of these have been mainly focussed on autologous sources, and for good reason. Issues relating to allogenic source have been consciously avoided owing to concerns of cross infectivity and immune rejection. However, this topic today is now revisited and is of interest since progress over the year has demonstrated its safety, efficacy, and its abundance of supply. The present systematic review was thus conducted to elucidate advances made in this area, with the aim to provide a wider and deeper understanding of studies relevant to the application of allogenic PRP in cartilage repair. Literature search was conducted systematically using Medline, ProQuest, Web of Science, Cochrane Central Register of Controlled Trials, and snowballing searching strategy to identify relevant studies using topic-specific keywords in various combinations including "allogenic, platelet, rich, plasma" OR "allogeneic, platelet, rich, plasma" OR "allogenic platelet-rich plasma" OR "allogeneic platelet-rich plasma" OR "allogenic platelet rich plasma" OR "allogeneic platelet rich plasma" AND cartilage OR chondrocytes OR synoviocytes OR stem cells. Studies that used allogenic PRP in an attempt to facilitate cartilage repair were included. The risk of bias was assessed by the SYRCLE's checklist. Of 206 studies identified, 12 were found eligible. Only those studies that are clearly related and specific to allogenic PRP were included. Of these, nine investigated the efficacy of allogenic PRP in animal models, while three articles employed an in vitro model. Allogenic PRP promotes cell proliferation, cartilage matrix production, and anti-inflammatory effects in vitro. The in vivo studies reported histological evidence of significant acceleration of cartilage repair in treated animals. Despite several conflicting findings, all studies agreed that allogenic PRP is safe and potentially efficacious for cartilage repair, with the advantages of allogenic sources apparent. It is apparent that whilst many reports are available regarding platelet-rich-plasma (PRP), the larger majority of these have been mainly focussed on autologous sources, and for good reason. Issues relating to allogenic source have been consciously avoided owing to concerns of cross infectivity and immune rejection. However, this topic today is now revisited and is of interest since progress over the year has demonstrated its safety, efficacy, and its abundance of supply. The present systematic review was thus conducted to elucidate advances made in this area, with the aim to provide a wider and deeper understanding of studies relevant to the application of allogenic PRP in cartilage repair. Literature search was conducted systematically using Medline, ProQuest, Web of Science, Cochrane Central Register of Controlled Trials, and snowballing searching strategy to identify relevant studies using topic-specific keywords in various combinations including "allogenic, platelet, rich, plasma" OR "allogeneic, platelet, rich, plasma" OR "allogenic platelet-rich plasma" OR "allogeneic platelet-rich plasma" OR "allogenic platelet rich plasma" OR "allogeneic platelet rich plasma" AND cartilage OR chondrocytes OR synoviocytes OR stem cells. Studies that used allogenic PRP in an attempt to facilitate cartilage repair were included. The risk of bias was assessed by the SYRCLE's checklist. Of 206 studies identified, 12 were found eligible. Only those studies that are clearly related and specific to allogenic PRP were included. Of these, nine investigated the efficacy of allogenic PRP in animal models, while three articles employed an in vitro model. Allogenic PRP promotes cell proliferation, cartilage matrix production, and anti-inflammatory effects in vitro. The in vivo studies reported histological evidence of significant acceleration of cartilage repair in treated animals. Despite several conflicting findings, all studies agreed that allogenic PRP is safe and potentially efficacious for cartilage repair, with the advantages of allogenic sources apparent. |
| Author | Kamarul, Tunku Looi, Qi Hao Daniel Ahmad, Raja Elina Chong, Pan Pan Hassan, Nur Hidayah |
| Author_xml | – sequence: 1 givenname: Nur Hidayah surname: Hassan fullname: Hassan, Nur Hidayah email: nurhidayah@unikl.edu.my, nurhidayah@unikl.edu.my organization: Investigative Biomedical Science Research Cluster (IBMS-RC), Clinical Laboratory Science Section, Institute of Medical Science Technology, Universiti Kuala Lumpur, Kajang, Malaysia, nurhidayah@unikl.edu.my – sequence: 2 givenname: Raja Elina surname: Ahmad fullname: Ahmad, Raja Elina organization: Department of Physiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia – sequence: 3 givenname: Tunku surname: Kamarul fullname: Kamarul, Tunku organization: Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia, George Town, Malaysia – sequence: 4 givenname: Qi Hao Daniel surname: Looi fullname: Looi, Qi Hao Daniel organization: My CytoHealth Sdn. Bhd., Lab 6, DMC Level 2, Hive 5, Taman Teknologi MRANTI, Kuala Lumpur, Malaysia – sequence: 5 givenname: Pan Pan surname: Chong fullname: Chong, Pan Pan organization: National Orthopaedic Centre of Excellence for Research and Learning (NOCERAL), Department of Orthopaedic Surgery, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37944499$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkMtOwzAQRS0EAlpY8APISzYBvxLH7ErFoxISFZR15TiTYuTYJXZA_RT-llBAYjVz7xydxYzQrg8eEDqh5JzSXF0QQnKeE1ruoEMqGMsKwejuv_0AjWJ8HTA2hH10wKUSQih1iD4nzoUVeGvw3OkEDlL2aM3Ld4qtxk3o8KIDnaxf4anuknV6BXjmX_tuc4kn-GkTE7TD3eBHeLfwgUOD0wvg63dbgzeAg9_mKx0H5snY7zJuxfOQwCerHb7pU98BnqzXzppBFnw8QnuNdhGOf-cYPd9cL6Z32f3D7Ww6uc8M5yJlmslKclbJhhLBKxCaFLViZc0bovK6LCTUsiyo0oUqyoqX1EjSKCkNENIUORujsx_vugtvPcS0bG004Jz2EPq4ZGWpmMhzxgf09Bftqxbq5bqzre42y793si8qP3hI |
| CitedBy_id | crossref_primary_10_3389_fvets_2025_1625431 crossref_primary_10_1016_j_ijbiomac_2025_143610 |
| ContentType | Journal Article |
| Copyright | 2023 S. Karger AG, Basel. |
| Copyright_xml | – notice: 2023 S. Karger AG, Basel. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1159/000535018 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Zoology Biology |
| EISSN | 1422-6421 |
| ExternalDocumentID | 37944499 |
| Genre | Systematic Review Journal Article |
| GroupedDBID | --- -~X .GJ 0R~ 0~5 0~B 29B 30W 326 34G 36B 39C 3O- 3O. 4.4 53G 5GY 6J9 7X7 88E 8AO 8FE 8FH 8FI 8FJ 8UI AAYIC ABBTS ABJNI ABPAZ ABUWG ABWCG ACGFS ACPRK ACPSR ADBBV ADFRT AENEX AEYAO AFJJK AFKRA AHFRZ AHMBA AI. ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AZPMC BBNVY BENPR BHPHI BPHCQ BVXVI C45 CAG CCPQU CGR COF CS3 CUY CVF CYUIP DU5 E0A EBS ECM EIF EJD EMB EMOBN F5P FB. FYUFA HCIFZ HMCUK HZ~ IY7 KUZGX L7B LK8 M1P M7P N9A NPM O1H O9- OVD PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO RIG RKO RXVBD SV3 TEORI UJ6 UKHRP VH1 7X8 |
| ID | FETCH-LOGICAL-c334t-a27b732b7f1043be4a06d928d3f095d867ed78619a6968b381c70f977ce00f652 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 5 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001105797900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1422-6421 |
| IngestDate | Sun Nov 09 14:13:45 EST 2025 Mon Jul 21 06:04:31 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Cartilage injury Allogenic platelet-rich-plasma Platelet concentrate Safety Immunogenicity |
| Language | English |
| License | 2023 S. Karger AG, Basel. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c334t-a27b732b7f1043be4a06d928d3f095d867ed78619a6968b381c70f977ce00f652 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 ObjectType-Review-4 content type line 23 |
| PMID | 37944499 |
| PQID | 2889245523 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2889245523 pubmed_primary_37944499 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-08-01 |
| PublicationDateYYYYMMDD | 2024-08-01 |
| PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Cells, tissues, organs |
| PublicationTitleAlternate | Cells Tissues Organs |
| PublicationYear | 2024 |
| SSID | ssj0002421 |
| Score | 2.4254625 |
| SecondaryResourceType | review_article |
| Snippet | It is apparent that whilst many reports are available regarding platelet-rich-plasma (PRP), the larger majority of these have been mainly focussed on... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 338 |
| SubjectTerms | Animals Cartilage Chondrocytes - transplantation Humans Platelet-Rich Plasma Transplantation, Homologous - methods |
| Title | Allogenic Platelet-Rich Plasma for Treating Cartilage Injury: A Systematic Review of the Evidence on the Basic Sciences for Potential Future Applications |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37944499 https://www.proquest.com/docview/2889245523 |
| Volume | 213 |
| WOSCitedRecordID | wos001105797900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwEA_qVHzxY37NLyL4WuyStkl9kToc-rBRcMLwpaRpI5PZTjsF_xT_Wy9p5nwRBF9KE9oQuMvld3fJ7xA64ywLlZfqEJjQoRvCHZ4CkOOhD3hdSY8QZYpNsH6fD4dhbANulT1WObOJxlBnpdQx8nPCObgKPvhNl5MXR1eN0tlVW0JjETUoQBmt1Ww4ZwvX6U5zuwgcLn2h0zILwQ5-XhObuG3-O7I0O0x3479z20TrFlviqFaGLbSQF020Uleb_Gii1Z7No0PnQ2k6t9FnNIaXvBhJHI8Bd4IYHX3ZXreqZ4EB0-KBAZbFI-5oPRuDBcK3xRMI4wJH-O6bChrXeQZcKgyoEs_qleKyMO0rAQqBrS2pzMBxOdWHlWDOXUNtgqMf6fQddN-9HnRuHFuuwZGUelNHEJYySlKmwMWjae4JN8hCwjOqAMdlPGB5xjg4bEIT8qQAFSRzFeBPmbuuCnyyi5aKssj3EYavglQwRYX29zwvZG2ZMcr8NuOKBaKFTmeCSGA56ByHKPLyrUrmomihvVqayaTm7Ugo2B4YKzz4w9-HaI2A_tRH_Y5QQ4ExyI_RsnyfjqrXE6Nn8OzHvS_SJdwW |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Allogenic+Platelet-Rich+Plasma+for+Treating+Cartilage+Injury%3A+A+Systematic+Review+of+the+Evidence+on+the+Basic+Sciences+for+Potential+Future+Applications&rft.jtitle=Cells%2C+tissues%2C+organs&rft.au=Hassan%2C+Nur+Hidayah&rft.au=Ahmad%2C+Raja+Elina&rft.au=Kamarul%2C+Tunku&rft.au=Looi%2C+Qi+Hao+Daniel&rft.date=2024-08-01&rft.eissn=1422-6421&rft.volume=213&rft.issue=4&rft.spage=338&rft_id=info:doi/10.1159%2F000535018&rft_id=info%3Apmid%2F37944499&rft_id=info%3Apmid%2F37944499&rft.externalDocID=37944499 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-6421&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-6421&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-6421&client=summon |